Abstracts

Stage II colon cancer: Epidemiological, clinical characteristics, and therapeutic results. Experience of the medical oncology department of Fez

Background Adjuvant chemotherapy is recommended in patients with stage II colon cancer with high-risk features. The objective of our study is to assess survival benefits...

Soukaina El Anssari ;

Zineb Benbrahim ;

Youssef Elhaitmy ;

Imad Elbadisy ;

Fouad Abbass ;

Lamiae Amaadour ;

Karima Oualla ;

Samia Arifi ;

06/27/2022

The effect of duration of induction therapy on survival in patients receiving maintenance therapy in the first line for metastatic colorectal cancer: A single-center retrospective analysis

Background Standard first-line treatment of metastatic colorectal cancer (mCRC) is combination chemotherapy with the addition of a biological agent. Several randomized c...

06/27/2022

Impact of COVID-19 on colorectal cancer management: Single-center experience

Background Colorectal cancer (CCR) is the third most common and the second most deadly cancer with 1.9 million new diagnoses worldwide in 2020. COVID-19 pandemic placed ...

06/27/2022

Impact of the IDEA collaboration results on the management of stage II-III colon cancer: 2 years of data from the medical oncology department in Marrakech, Morocco

Background For many years, adjuvant fluoropyrimidine-based chemotherapy for 6 months has been the standard of care in stage II-III colon cancer with an improved overall ...

06/27/2022

GA CPI 613: A single-arm, open-label phase I study of CPI-613 in combination with gemcitabine and nab-paclitaxel for patients with locally advanced or metastatic pancreatic cancer

Background Pancreatic cancer is the third leading cause of cancer death in the USA with current standard of care treatments that have moderate toxicity and median overal...

06/27/2022

Real-world outcomes of anal cancer patients treated with radical chemoradiation

Background Anal squamous cell carcinoma (SCC) is an uncommon malignancy of all cancers of the lower intestinal tract. Concurrent chemoradiation (ChRT) with 5-fluorouraci...

06/27/2022

An eleven-lncRNA signature predicts overall survival in patients with gastric cancer

Background Gastric cancer (GC) is one of the most common malignancies worldwide. Multidisciplinary strategies including chemotherapy, radiotherapy and surgical resection...

06/27/2022

Association between tumor differentiation grade and TNM staging in colorectal cancer

Background The tumor differentiation grade has been shown by several studies to be a stage-independent prognostic factor in colorectal cancer (CRC) 1. It is a factor tha...

06/27/2022

Тoxicity and tolerability of the mFOLFIRINOX regimen in young elderly and older elderly patients with pancreatic carcinoma (PC)

Background Currently, the median age of PC patients is about 70 years. By 2030 nearly 70% of PC are expected to be diagnosed in the elderly. These patients are poorly re...

06/27/2022

Elevated protein tyrosine phosphatase kappa expression is associated with disease progression and poor prognosis of pancreatic cancer

Background Protein tyrosine phosphatase kappa (PTPRK) is a phosphatase which is recognised as a tumour suppressor. PTPRK can promote the internalization of ZNRF3 by deph...

06/27/2022